Davidson Kempner Capital Management LP Horizon Therapeutics Public LTD CO Transaction History

Davidson Kempner Capital Management LP

  • $3.92 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$98.98 - $115.74 $139 Million - $162 Million
-1,402,135 Reduced 31.31%
3,076,379 $356 Million
Q2 2023

Nov 14, 2023
BUY
$96.34 - $112.38 $17.7 Million - $20.7 Million
183,812 Added 5.97%
3,260,191 $335 Million
Q1 2023

Nov 14, 2023
BUY
$107.32 - $113.5 $207 Million - $218 Million
1,924,861 Added 75.38%
4,478,514 $489 Million
Q4 2022

Nov 14, 2023
BUY
$62.39 - $113.8 $159 Million - $291 Million
2,553,653 New
2,553,653 $291 Million

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Davidson Kempner Capital Management LP Portfolio

Follow Davidson Kempner Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Kempner Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Davidson Kempner Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email